These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17826684)

  • 1. Dissecting kinase signaling pathways.
    Boyle SN; Koleske AJ
    Drug Discov Today; 2007 Sep; 12(17-18):717-24. PubMed ID: 17826684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinase inhibitors and their resistance].
    Togashi Y; Nishio K
    Nihon Rinsho; 2015 Aug; 73(8):1323-9. PubMed ID: 26281685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineoplastic agents targeting tyrosine kinases].
    Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular target therapy for malignant tumors].
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular targeted therapy for malignant brain tumors].
    Okamura T; Kurisu K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():520-6. PubMed ID: 16201575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problems in the current target therapy of malignancies].
    Stukov AN; Gershanovich ML; Filov VA; Imianitov EN
    Vopr Onkol; 2005; 51(5):607-11. PubMed ID: 16756022
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting tyrosine kinases in cancer: the second wave.
    Baselga J
    Science; 2006 May; 312(5777):1175-8. PubMed ID: 16728632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinases as drug targets in cancer.
    Arslan MA; Kutuk O; Basaga H
    Curr Cancer Drug Targets; 2006 Nov; 6(7):623-34. PubMed ID: 17100568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular targeted therapy].
    Stenner-Liewen F; Zippelius A; Pestalozzi BC; Knuth A
    Chirurg; 2006 Dec; 77(12):1118-25. PubMed ID: 17109101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II kinase inhibitors: an opportunity in cancer for rational design.
    Blanc J; Geney R; Menet C
    Anticancer Agents Med Chem; 2013 Jun; 13(5):731-47. PubMed ID: 23094911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversing resistance to targeted therapy.
    Vidal L; Attard G; Kaye S; De Bono J
    J Chemother; 2004 Nov; 16 Suppl 4():7-12. PubMed ID: 15688600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance.
    Levitzki A
    Annu Rev Pharmacol Toxicol; 2013; 53():161-85. PubMed ID: 23043437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autophagy in hematologic malignancies].
    Adachi S
    Rinsho Ketsueki; 2009 Oct; 50(10):1531-8. PubMed ID: 19915363
    [No Abstract]   [Full Text] [Related]  

  • 14. Researchers optimistic about sea change in cancer treatment.
    Stephenson J
    JAMA; 2001 Jun; 285(22):2841-2. PubMed ID: 11401587
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibiting tyrosine kinases: successes and limitations.
    Arteaga CL
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S79-83. PubMed ID: 14508084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tyrosine kinase inhibitors in tumor therapy--part 2. Current position and perspectives].
    Grimm CF; Blum HE; Geissler M
    Dtsch Med Wochenschr; 2005 Jun; 130(23):1438-42. PubMed ID: 15929020
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond chemotherapy--demystifying the new 'targeted' cancer treatments.
    Dear R; Wilcken N; Shannon J
    Aust Fam Physician; 2008; 37(1-2):45-9. PubMed ID: 18239753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinase inhibitors].
    Yamori T; Kong D
    Nihon Rinsho; 2010 Jun; 68(6):1059-66. PubMed ID: 20535956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into oncogene addiction found.
    Garber K
    J Natl Cancer Inst; 2007 Feb; 99(4):264-5, 269. PubMed ID: 17312299
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.